Weyco Group fails Nasdaq independent director rule after director resignation; cure period granted

WEYCO GROUP INC

Director Robert Feitler resigned Feb 28, 2025, causing non-compliance with Nasdaq Listing Rule 5605(b)(1) requiring majority independent directors.
Nasdaq notified Weyco on Mar 4, 2025 of non-compliance; cure period extends until earlier of next annual meeting or Feb 28, 2026.
If next annual meeting is before Aug 27, 2025, compliance must be shown by Aug 27, 2025.
Company is actively searching for new independent director candidates; no assurance of regaining compliance.

item 3.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Robert Feitler

Director

WEYS · WEYCO GROUP INC

Effective: 2025-02-28
Filed: March 12, 2025, 7:59 PM ET

Mr. Robert Feitler from the Company’s Board of Directors (the “Board”) effective February 28, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert Feitler resigned as Director at WEYCO GROUP INC.

Action: resigned
Role: Director

Exact text from the filing

Mr. Robert Feitler from the Company’s Board of Directors (the “Board”) effective February 28, 2025

View on SEC.gov

WEYCO GROUP INC filing history →

Source: SEC EDGAR

accession 0001558370-25-002805

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.